274 related articles for article (PubMed ID: 22841785)
1. Inhibition of MKK7-JNK by the TOR signaling pathway regulator-like protein contributes to resistance of HCC cells to TRAIL-induced apoptosis.
Song IS; Jun SY; Na HJ; Kim HT; Jung SY; Ha GH; Park YH; Long LZ; Yu DY; Kim JM; Kim JH; Ko JH; Kim CH; Kim NS
Gastroenterology; 2012 Nov; 143(5):1341-1351. PubMed ID: 22841785
[TBL] [Abstract][Full Text] [Related]
2. Novel TRAIL sensitizer Taraxacum officinale F.H. Wigg enhances TRAIL-induced apoptosis in Huh7 cells.
Yoon JY; Cho HS; Lee JJ; Lee HJ; Jun SY; Lee JH; Song HH; Choi S; Saloura V; Park CG; Kim CH; Kim NS
Mol Carcinog; 2016 Apr; 55(4):387-96. PubMed ID: 25647515
[TBL] [Abstract][Full Text] [Related]
3. Receptor for activated C kinase 1 promotes hepatocellular carcinoma growth by enhancing mitogen-activated protein kinase kinase 7 activity.
Guo Y; Wang W; Wang J; Feng J; Wang Q; Jin J; Lv M; Li X; Li Y; Ma Y; Shen B; Zhang J
Hepatology; 2013 Jan; 57(1):140-51. PubMed ID: 22903704
[TBL] [Abstract][Full Text] [Related]
4. A positive role of mammalian Tip41-like protein, TIPRL, in the amino-acid dependent mTORC1-signaling pathway through interaction with PP2A.
Nakashima A; Tanimura-Ito K; Oshiro N; Eguchi S; Miyamoto T; Momonami A; Kamada S; Yonezawa K; Kikkawa U
FEBS Lett; 2013 Sep; 587(18):2924-9. PubMed ID: 23892082
[TBL] [Abstract][Full Text] [Related]
5. Tussilago farfara L. augments TRAIL-induced apoptosis through MKK7/JNK activation by inhibition of MKK7‑TIPRL in human hepatocellular carcinoma cells.
Lee HJ; Cho HS; Jun SY; Lee JJ; Yoon JY; Lee JH; Song HH; Choi SH; Kim SY; Saloura V; Park CG; Kim NS
Oncol Rep; 2014 Sep; 32(3):1117-23. PubMed ID: 24969837
[TBL] [Abstract][Full Text] [Related]
6. Novel indazole-based small compounds enhance TRAIL-induced apoptosis by inhibiting the MKK7-TIPRL interaction in hepatocellular carcinoma.
Yoon JY; Lee JJ; Gu S; Jung ME; Cho HS; Lim JH; Jun SY; Ahn JH; Min JS; Choi MH; Jeon SJ; Lee YJ; Go A; Heo YJ; Jung CR; Choi G; Lee K; Jeon MK; Kim NS
Oncotarget; 2017 Dec; 8(68):112610-112622. PubMed ID: 29348850
[TBL] [Abstract][Full Text] [Related]
7. Components of the JNK-MAPK pathway play distinct roles in hepatocellular carcinoma.
Yu J; Li X; Cao J; Zhu T; Liang S; Du L; Cao M; Wang H; Zhang Y; Zhou Y; Shen B; Feng J; Zhang J; Wang J; Jin J
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17495-17509. PubMed ID: 37902853
[TBL] [Abstract][Full Text] [Related]
8. Cordycepin promotes apoptosis in renal carcinoma cells by activating the MKK7-JNK signaling pathway through inhibition of c-FLIPL expression.
Hwang IH; Oh SY; Jang HJ; Jo E; Joo JC; Lee KB; Yoo HS; Lee MY; Park SJ; Jang IS
PLoS One; 2017; 12(10):e0186489. PubMed ID: 29045468
[TBL] [Abstract][Full Text] [Related]
9. Interaction analysis of the heterotrimer formed by the phosphatase 2A catalytic subunit, alpha4 and the mammalian ortholog of yeast Tip41 (TIPRL).
Smetana JH; Zanchin NI
FEBS J; 2007 Nov; 274(22):5891-904. PubMed ID: 17944932
[TBL] [Abstract][Full Text] [Related]
10. JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.
Mucha SR; Rizzani A; Gerbes AL; Camaj P; Thasler WE; Bruns CJ; Eichhorst ST; Gallmeier E; Kolligs FT; Göke B; De Toni EN
Gut; 2009 May; 58(5):688-98. PubMed ID: 19106147
[TBL] [Abstract][Full Text] [Related]
11. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
12. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
13. Cordycepin increases sensitivity of Hep3B human hepatocellular carcinoma cells to TRAIL-mediated apoptosis by inactivating the JNK signaling pathway.
Lee HH; Jeong JW; Lee JH; Kim GY; Cheong J; Jeong YK; Yoo YH; Choi YH
Oncol Rep; 2013 Sep; 30(3):1257-64. PubMed ID: 23828231
[TBL] [Abstract][Full Text] [Related]
14. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
16. TRAIL-induced apoptosis of hepatocellular carcinoma cells is augmented by targeted therapies.
Koehler BC; Urbanik T; Vick B; Boger RJ; Heeger S; Galle PR; Schuchmann M; Schulze-Bergkamen H
World J Gastroenterol; 2009 Dec; 15(47):5924-35. PubMed ID: 20014456
[TBL] [Abstract][Full Text] [Related]
17. The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells.
Song P; Yang S; Hua H; Zhang H; Kong Q; Wang J; Luo T; Jiang Y
J Biol Chem; 2019 Apr; 294(15):5945-5955. PubMed ID: 30782845
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression.
Wu JR; Hu CT; You RI; Pan SM; Cheng CC; Lee MC; Wu CC; Chang YJ; Lin SC; Chen CS; Lin TY; Wu WS
Oncotarget; 2015 Oct; 6(32):32526-44. PubMed ID: 26416447
[TBL] [Abstract][Full Text] [Related]
20. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
